Valuation: Feedback plc

Market Cap 27.82L 36.88L 32.44L 30.67L 52.25L 35Cr 52.55L 3.67Cr 1.42Cr 18Cr 1.38Cr 1.35Cr 58Cr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 8L 10.61L 9L 9L 15.04L 10Cr 15.12L 1.06Cr 40.82L 5.2Cr 39.85L 38.99L 17Cr EV / Sales 2026 *
0.99x
EV / Sales 2027 * 4.56x
Free-Float
94.51%
Yield 2026 *
-
Yield 2027 * -
Current month-7.30%
1 month-7.30%
3 months-10.56%
6 months-51.15%
Current year-34.03%
1 week 6.3
Extreme 6.3
6.4
1 month 6.3
Extreme 6.3
7
Current year 5.8
Extreme 5.8
15
1 year 5.8
Extreme 5.8
15
3 years 5.8
Extreme 5.8
152.92
5 years 5.8
Extreme 5.8
274.8
10 years 5.8
Extreme 5.8
1,040
Manager TitleAgeSince
Chief Executive Officer 38 09/04/2019
Director of Finance/CFO 54 10/11/2025
Compliance Officer 56 01/02/2001
Director TitleAgeSince
Director/Board Member 38 09/04/2019
Chairman 72 18/11/2019
Director/Board Member 55 03/02/2020
Date Insider Type Main position Quantity % Market Cap. Importance
23/12/25 Buy

Chief Executive Officer

60,904 0.1390%
23/12/25 Buy

Chief Financial Officer

60,549 0.1382%
10/07/25 Free

Public Communications Manager

2,19,073 0.5000%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-40.93%-92.06% 36.88L
-1.26%+6.64%-5.04%+36.76% 4.53TCr
+0.99%-0.35%-45.70%+96.38% 1.19TCr
+2.15%+4.42%-5.30%+126.43% 556.85Cr
-1.28%-2.07%+42.41% - 434.07Cr
-0.84%-14.86% - - 191.37Cr
-0.58%+1.15%+10.58%-25.51% 154.5Cr
-1.95%-4.29%+7.51%+136.21% 96Cr
-0.68%-5.48%+30.07%+35.16% 85Cr
-0.58%-0.29%-28.09%-49.11% 79Cr
Average -0.38%-1.39%-3.83%+33.03% 731.94Cr
Weighted average by Cap. -0.50%+3.79%-8.28%+53.76%

Financials

2026 *2027 *
Net sales 8L 10.74L 9L 9L 15.21L 10Cr 15.3L 1.07Cr 41.3L 5.26Cr 40.31L 39.44L 17Cr 8L 10.74L 9L 9L 15.21L 10Cr 15.3L 1.07Cr 41.3L 5.26Cr 40.31L 39.44L 17Cr
Net income - -
Net Debt -19.82L -26.27L -23.1L -21.85L -37.21L -25Cr -37.43L -2.62Cr -1.01Cr -13Cr -98.62L -96.49L -41Cr 9L 12.12L 10.66L 10.08L 17.17L 12Cr 17.27L 1.21Cr 46.6L 5.94Cr 45.5L 44.51L 19Cr
Logo Feedback plc
Feedback plc is a United Kingdom-based clinical infrastructure specialist. The Company designs products that enhance clinician access to patient data and to their colleagues. The Company's approach centers around individual patient episodes, into which it pulls relevant clinical data from hospital systems and around which it builds remote clinical teams for collaboration. The Company’s segments include Medical Imaging and Feedback Medical Imaging India. Its products include Bleepa and CareLocker. Bleepa is its application layer and sits on top of CareLocker as its data layer. Bleepa is its communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multidisciplinary team working and diagnostic-enhanced advice and guidance. CareLocker is its patient-facing platform that gives patients access and control over their diagnostic and other clinical data.
Employees
29
Date Price Change Volume
29/26/29 GBX 6.350 0.00% 35,700
28/26/28 GBX 6.350 0.00% 6,066
25/26/25 GBX 6.350 0.00% 0
24/26/24 GBX 6.350 0.00% 3,170
23/26/23 GBX 6.350 0.00% 318
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0635GBP
Average target price
0.6000GBP
Spread / Average Target
+844.88%

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. FDBK Stock